| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
6 companies
Adar1 Capital Management, LLC is a 10% Owner at TENX, with reported holdings spanning 6 companies. Recent filings cover 63 purchases and 3 sales. Those positions are worth an estimated $32.1M at current prices.
Our model assigns Adar1 Capital Management, LLC a strong insider score of 78/100, based on 6 past trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +73.6%.
Adar1 Capital Management, LLC's largest disclosed position is in RLYB as 10% Owner, worth about $12.9M. Net of sales, the recent Form 4 record there shows accumulation of 302,473 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 21, 2026 | TENX Tenax Therapeutics, Inc. | 10% Owner | Buy | 922,849 | $1.59 | $1,463,426.21 | +14.1% | - | - | |
| Oct 19, 2026 | INM Inmed Pharmaceuticals Inc. | 10% Owner | Buy | 1,087 | $1.32 | $1,434.84 | +0.1% | - | - | |
| Oct 15, 2026 | INM Inmed Pharmaceuticals Inc. | 10% Owner | Buy | 9,569 | $1.33 | $12,718.80 | +1.0% | - | - | |
| Oct 8, 2026 | INM Inmed Pharmaceuticals Inc. | 10% Owner | Buy | 10,903 | $1.33 | $14,484.27 | +1.2% | - | - | |
| Oct 5, 2026 | INM Inmed Pharmaceuticals Inc. | 10% Owner | Buy | 42,920 | $1.33 | $57,080.31 | +4.8% | - | - | |
| Sep 16, 2026 | INM Inmed Pharmaceuticals Inc. | 10% Owner | Buy | 91,101 | $1.30 | $118,076.02 | +11.4% | - | - | |
| Sep 3, 2026 | TENX Tenax Therapeutics, Inc. | 10% Owner | Buy | 900,000 | $1.78 | $1,604,160.00 | +16.0% | - | - | |
| Sep 2, 2026 | TENX Tenax Therapeutics, Inc. | 10% Owner | Buy | 770,333 | $1.79 | $1,381,749.78 | +15.9% | - | - | |
| Aug 24, 2026 | TENX Tenax Therapeutics, Inc. | 10% Owner | Buy | 1,025,867 | $1.77 | $1,814,147.49 | +26.8% | - | - | |
| Jul 31, 2026 | NXTC Nextcure, Inc. | 10% Owner | Buy | 329,153 | $4.93 | $1,624,120.50 | +83.7% | - | - |